BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 23937603)

  • 1. Incidence and risk factors of herpes zoster among hiv-positive patients in the german competence network for HIV/AIDS (KompNet): a cohort study analysis.
    Jansen K; Haastert B; Michalik C; Guignard A; Esser S; Dupke S; Plettenberg A; Skaletz-Rorowski A; Brockmeyer NH
    BMC Infect Dis; 2013 Aug; 13():372. PubMed ID: 23937603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence of herpes zoster in HIV-infected adults in the combined antiretroviral therapy era: results from the FHDH-ANRS CO4 cohort.
    Grabar S; Tattevin P; Selinger-Leneman H; de La Blanchardiere A; de Truchis P; Rabaud C; Rey D; Daneluzzi V; Ferret S; Lascaux AS; Hanslik T; Costagliola D; Launay O;
    Clin Infect Dis; 2015 Apr; 60(8):1269-77. PubMed ID: 25601456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short-term and long-term effects of highly active antiretroviral therapy on the incidence of herpes zoster in HIV-infected children.
    Levin MJ; Anderson JP; Seage GR; Williams PL;
    J Acquir Immune Defic Syndr; 2009 Feb; 50(2):182-91. PubMed ID: 19131890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Antiretroviral Therapy on the Risk of Herpes Zoster among Human Immunodeficiency Virus-Infected Individuals in Tanzania.
    Kawai K; Hawkins CA; Hertzmark E; Francis JM; Sando D; Muya AN; Ulenga N; Fawzi WW
    Am J Trop Med Hyg; 2018 Feb; 98(2):396-401. PubMed ID: 29313475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Herpes zoster among persons living with HIV in the current antiretroviral therapy era.
    Blank LJ; Polydefkis MJ; Moore RD; Gebo KA
    J Acquir Immune Defic Syndr; 2012 Oct; 61(2):203-7. PubMed ID: 22766968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence and risk factors of herpes zoster in human immunodeficiency virus-positive patients initiating combination antiretroviral therapy in Taiwan.
    Lee YC; Hung CC; Tsai MS; Zhang JY; Wu PY; Yang SP; Luo YZ; Chang HY; Liu WC; Sun HY; Chang SC
    J Microbiol Immunol Infect; 2018 Feb; 51(1):38-44. PubMed ID: 27329131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence and predictors of herpes zoster among antiretroviral therapy-naïve patients initiating HIV treatment in Johannesburg, South Africa.
    Shearer K; Maskew M; Ajayi T; Berhanu R; Majuba P; Sanne I; Fox MP
    Int J Infect Dis; 2014 Jun; 23():56-62. PubMed ID: 24680820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Herpes zoster in HIV-1-infected patients in the era of highly active antiretroviral therapy: a prospective observational study.
    Hung CC; Hsiao CF; Wang JL; Chen MY; Hsieh SM; Sheng WH; Chang SC
    Int J STD AIDS; 2005 Oct; 16(10):673-6. PubMed ID: 16212714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary varicella and herpes zoster among HIV-infected children from 1989 to 2006.
    Wood SM; Shah SS; Steenhoff AP; Rutstein RM
    Pediatrics; 2008 Jan; 121(1):e150-6. PubMed ID: 18086820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of mortality within the first year of initiating antiretroviral therapy in urban and rural Kenya: A prospective cohort study.
    Silverman RA; John-Stewart GC; Beck IA; Milne R; Kiptinness C; McGrath CJ; Richardson BA; Chohan B; Sakr SR; Frenkel LM; Chung MH
    PLoS One; 2019; 14(10):e0223411. PubMed ID: 31584992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiological composition, clinical and treatment characteristics of the patient cohort of the German Competence Network for HIV/AIDS.
    Jansen K; Brockmeyer NH; Hahn M; Kaul I; Fenske S; Rausch M; Kuhlmann B; Ulmer A; Lauenroth-Mai E; Harrer T; Hower M; Skaletz-Rorowski A; Michalik C;
    Eur J Med Res; 2009 Sep; 14(10):415-25. PubMed ID: 19748848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The incidence of, risk factors for, and sequelae of herpes zoster among HIV patients in the highly active antiretroviral therapy era.
    Gebo KA; Kalyani R; Moore RD; Polydefkis MJ
    J Acquir Immune Defic Syndr; 2005 Oct; 40(2):169-74. PubMed ID: 16186734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence and risk factors for herpes zoster following heart transplantation.
    Koo S; Gagne LS; Lee P; Pratibhu PP; James LM; Givertz MM; Marty FM
    Transpl Infect Dis; 2014 Feb; 16(1):17-25. PubMed ID: 24147978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreasing incidence of herpes zoster in the highly active antiretroviral therapy era.
    Moanna A; Rimland D
    Clin Infect Dis; 2013 Jul; 57(1):122-5. PubMed ID: 23487391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Herpes zoster as an immune restoration disease in AIDS patients during therapy including protease inhibitors.
    Dunić I; Djurković-Djaković O; Vesić S; Zerjav S; Jevtović D
    Int J STD AIDS; 2005 Jul; 16(7):475-8. PubMed ID: 16004625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune Correlates of Herpes Zoster in People Living with HIV on Effective Antiretroviral Therapy.
    Tovar Salazar A; McKhann A; Chen H; Bosch RJ; Weinberg A
    AIDS Res Hum Retroviruses; 2019 Oct; 35(10):890-895. PubMed ID: 31179712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased Incidence of Herpes Zoster and Postherpetic Neuralgia in Adult Patients following Traumatic Brain Injury: A Nationwide Population-Based Study in Taiwan.
    Tung YC; Tu HP; Tsai WC; Chen CS; Su CH; Shi HY; Lin CL
    PLoS One; 2015; 10(6):e0129043. PubMed ID: 26065420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Herpes zoster could be an early manifestation of undiagnosed human immunodeficiency virus infection.
    Lai SW; Lin CL; Liao KF; Chen WC
    J Formos Med Assoc; 2016 May; 115(5):372-6. PubMed ID: 26395527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mortality and loss to follow-up among HIV-infected persons on long-term antiretroviral therapy in Latin America and the Caribbean.
    Carriquiry G; Fink V; Koethe JR; Giganti MJ; Jayathilake K; Blevins M; Cahn P; Grinsztejn B; Wolff M; Pape JW; Padgett D; Madero JS; Gotuzzo E; McGowan CC; Shepherd BE
    J Int AIDS Soc; 2015; 18(1):20016. PubMed ID: 26165322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Herpes zoster, immunological deterioration and disease progression in HIV-1 infection.
    Veenstra J; Krol A; van Praag RM; Frissen PH; Schellekens PT; Lange JM; Coutinho RA; van der Meer JT
    AIDS; 1995 Oct; 9(10):1153-8. PubMed ID: 8519451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.